[ABT] ABT Dividend Analysis: Is Abbott Laboratories a Buy Now?
Wall Street Analyst Insight: In the current high-interest-rate environment, sophisticated investors are pivoting toward proven “Dividend Kings” to hedge against market volatility. This ABT Dividend Analysis evaluates Abbott Laboratories’ ability to maintain its prestigious 52-year streak of dividend increases. As a diversified healthcare leader, Abbott provides a unique blend of defensive stability and growth potential, … Read more